Clinical Trial Update: Arsenic Trioxide Plus Radiation Therapy in Treating Patients With Newly Diagnosed Malignant Glioma [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating arsenic trioxide with radiation therapy in newly diagnosed malignant glioma; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Giant Cell Glioblastoma
• Glioblastoma
• Gliosarcoma

Drugs mentioned

• Arsenic Trioxide (arsenic trioxide)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Adult Giant Cell Glioblastoma, Adult Glioblastoma | Phase 1 | Status: COMPLETED